← Back to Clinical Trials
Recruiting NCT07711132

NCT07711132 Remineralizing Effect of Nano-eggshell, Casein Phosphopeptide Amorphous Calcium Phosphate (CPP-ACP), and Sodium Fluoride on Initial Enamel Caries

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07711132
Status Recruiting
Phase —
Sponsor Mansoura University
Condition Initial Dental Caries
Study Type INTERVENTIONAL
Enrollment 90 participants
Start Date 2025-12-20
Primary Completion 2026-12-20

Eligibility & Interventions

Sex All sexes
Min Age 15 Years
Max Age 20 Years
Study Type INTERVENTIONAL
Interventions
nano-eggshell varnishCasein Phosphopeptide-Amorphous Calcium Phosphate (CPP-ACP)Dental PasteSodium Fluoride Varnish (5%)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 90 participants in total. It began in 2025-12-20 with a primary completion date of 2026-12-20.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This randomized controlled clinical trial aims to evaluate and compare the remineralizing effect of nano-eggshell varnish, CPP-ACP paste (GC Tooth Mousse), and sodium fluoride varnish on initial enamel caries among adolescents aged 15-20 years. Participants will be randomly allocated into three groups. Remineralization and caries activity will be assessed using DIAGNOdent readings, International Caries Classification and Management System (ICCMS) criteria, and the decayed, missed, and filled surfaces (DMFS) index over a 12-month follow-up period.

Eligibility Criteria

Inclusion Criteria: Patients' ages should be 15-20 years. Patients should have at least three to four teeth with ICDAS II scores of 1-2. Patients should have moderate-to-high caries risk. Exclusion Criteria: Known hypersensitivity to one of the components of the material under study. Systemic disorders or medication interfering with normal salivary flow.

Contact & Investigator

Central Contact

Ghada E Elhindawy

✉ ghada.ezzat91@yahoo.com

📞 00201102668577

Frequently Asked Questions

Who can join the NCT07711132 clinical trial?

This trial is open to participants of all sexes, aged 15 Years or older, up to 20 Years, studying Initial Dental Caries. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07711132 currently recruiting?

Yes, NCT07711132 is actively recruiting participants. Contact the research team at ghada.ezzat91@yahoo.com for enrollment information.

Where is the NCT07711132 trial being conducted?

This trial is being conducted at Al Mansurah, Egypt.

Who is sponsoring the NCT07711132 clinical trial?

NCT07711132 is sponsored by Mansoura University. The trial plans to enroll 90 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology